“Seeing the people in action, the great work that’s going on here, it is phenomenal. It’s helping us to beat this pandemic.” -Tom Gonzales, Larimer County Health Director
The director of the Cornell Veterinary Biobank will discuss using blood and tissue samples for the purposes of biomedical research.
Colorado State University’s spending on research activities reached a record $407 million for fiscal year 2020, a 2% increase over last year.
Since the start of the coronavirus pandemic, Colorado State University has received more than $16 million in funding for COVID-19 research projects.
A group of Colorado State University employees recently participated in a study to test asymptomatic essential CSU staff who worked on campus for more than 20 hours a week during the Colorado “stay-at-home” and “safer-at-home” orders.
The strategy relies on quick identification and isolation of individuals on campus infected with coronavirus.
Researchers at CSU have worked quickly and collaboratively to move this vaccine research forward.
The Columbine Health Systems Center for Healthy Aging at CSU has amassed one of the largest archives of longitudinally collected human samples of COVID-19.
Sen. Cory Gardner was on campus to learn about CSU's work in testing, senior care facility surveillance and vaccine development.
The team has licensed their viral RNA-testing platform to Quara Devices, a startup company specializing in diagnostic biosensors.